Sex-Specific Differences Seen in Link Between Exercise and All-Cause, CVD Death
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 20, 2024 -- Sex-specific differences are seen in the association between leisure-time physical activity and all-cause and cardiovascular death, according to a study published in the Feb. 27 issue of the Journal of the American College of Cardiology.
Hongwei Ji, M.D., from Beijing Tsinghua Changgung Hospital, and colleagues examined whether physical activity-derived health benefits differ by sex in a prospective study of 412,413 U.S. adults (55 percent female). The sex-specific multivariable-adjusted associations of physical activity measures were examined along with all-cause and cardiovascular mortality from 1997 through 2019.
The researchers found there were 39,935 all-cause deaths, including 11,670 cardiovascular deaths, during 4,911,178 person-years of follow-up. Compared with inactivity, regular leisure-time physical activity was associated with a reduced risk for all-cause mortality in women and men (hazard ratios, 0.76 and 0.85, respectively). For men, the maximal survival benefit (hazard ratio, 0.81) was achieved from 300 minutes/week of moderate-to-vigorous physical activity; women achieved a similar benefit at 140 minutes/week and continued to reach maximum survival benefit (hazard ratio, 0.76) at about 300 minutes/week. Similar sex-specific findings were seen for cardiovascular death; findings were consistent across all measures of aerobic activity and muscle-strengthening activity.
"Women compared with men derived greater gains in all-cause and cardiovascular mortality risk reduction from equivalent doses of leisure-time physical activity," the authors write. "These findings could motivate efforts to close the 'gender gap' by encouraging especially women to engage in any regular leisure-time physical activity."
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
342 Cardiology Clinics Acquired by Private Equity Firms in 2013 to 2023
WEDNESDAY, July 3, 2024 -- From 2013 to 2023, 342 cardiology clinics were acquired by private equity firms, with 94.7 percent of the acquisitions occurring between 2021 and 2023...
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.